Ad is loading...
PTGX
Price
$41.11
Change
+$0.07 (+0.17%)
Updated
Nov 15 closing price
121 days until earnings call
VIR
Price
$8.01
Change
-$0.63 (-7.29%)
Updated
Nov 15 closing price
95 days until earnings call
Ad is loading...

PTGX vs VIR

Header iconPTGX vs VIR Comparison
Open Charts PTGX vs VIRBanner chart's image
Protagonist Therapeutics
Price$41.11
Change+$0.07 (+0.17%)
Volume$1.09M
CapitalizationN/A
Vir Biotechnology
Price$8.01
Change-$0.63 (-7.29%)
Volume$1.48M
CapitalizationN/A
PTGX vs VIR Comparison Chart
Loading...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PTGX vs. VIR commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTGX is a Sell and VIR is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (PTGX: $41.11 vs. VIR: $8.01)
Brand notoriety: PTGX and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTGX: 175% vs. VIR: 144%
Market capitalization -- PTGX: $2.45B vs. VIR: $1.1B
PTGX [@Biotechnology] is valued at $2.45B. VIR’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTGX’s FA Score shows that 2 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • PTGX’s FA Score: 2 green, 3 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, PTGX is a better buy in the long-term than VIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTGX’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 3 bullish TA indicator(s).

  • PTGX’s TA Score: 5 bullish, 5 bearish.
  • VIR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than VIR.

Price Growth

PTGX (@Biotechnology) experienced а -11.08% price change this week, while VIR (@Biotechnology) price change was -16.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PTGX is expected to report earnings on Mar 18, 2025.

VIR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.45B) has a higher market cap than VIR($1.1B). PTGX YTD gains are higher at: 79.285 vs. VIR (-20.378). PTGX has higher annual earnings (EBITDA): 156M vs. VIR (-525.76M). VIR has more cash in the bank: 1.15B vs. PTGX (564M). PTGX has less debt than VIR: PTGX (11M) vs VIR (115M). PTGX has higher revenues than VIR: PTGX (319M) vs VIR (57.6M).
PTGXVIRPTGX / VIR
Capitalization2.45B1.1B222%
EBITDA156M-525.76M-30%
Gain YTD79.285-20.378-389%
P/E Ratio15.00N/A-
Revenue319M57.6M554%
Total Cash564M1.15B49%
Total Debt11M115M10%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTGXVIR
RSI
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEIPX46.22-0.18
-0.39%
Vanguard Equity-Income Inv
SUPAX18.36-0.23
-1.24%
DWS Equity Sector Strategy Fund Class A
HFDYX21.12-0.27
-1.26%
Hartford Schroders US MidCap Opps Y
WMKGX25.67-0.43
-1.65%
WesMark Large Company Fund
SBPYX42.05-0.74
-1.73%
ClearBridge Small Cap Growth I

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+0.17%
VIR - PTGX
41%
Loosely correlated
-7.29%
VRDN - PTGX
41%
Loosely correlated
-6.93%
ACLX - PTGX
40%
Loosely correlated
-7.63%
ALEC - PTGX
40%
Loosely correlated
-17.21%
ARDX - PTGX
40%
Loosely correlated
+5.52%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with ADPT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-7.29%
ADPT - VIR
52%
Loosely correlated
-8.96%
CRSP - VIR
51%
Loosely correlated
+0.85%
TECH - VIR
49%
Loosely correlated
-6.85%
NTLA - VIR
48%
Loosely correlated
-7.61%
AVIR - VIR
48%
Loosely correlated
-2.72%
More